Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. filings document operating results, governance matters and material events for a public ethical food company built around pasture-raised eggs and related food products. Form 8-K reports furnish earnings releases, Regulation FD updates, product portfolio actions and exit or disposal activity tied to butter offerings.
Proxy and stockholder-meeting disclosures cover director elections, board structure, executive compensation advisory votes, governance policies and shareholder voting results. Other current reports document board appointments, board leadership transitions, committee service, indemnification arrangements and related corporate-governance matters for the Nasdaq-listed Delaware public benefit corporation.
Vital Farms insider sale reported on Form 4. Joanne Bal, listed as General Counsel, Secretary and Head of Impact and an officer of Vital Farms, sold 4,796 shares of Common Stock on 08/22/2025 at a price of $50.95 per share. Following the sale, the filing reports 43,332 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 08/26/2025.
Matthew Ohayer, Executive Chairperson, Director and 10% owner of Vital Farms, Inc. (VITL) reported a sale of 4,200 shares of common stock on 08/21/2025 at $50.25 per share executed under a Rule 10b5-1 trading plan adopted March 14, 2025. Following the reported sale, Mr. Ohayer directly beneficially owns 6,827,070 shares. He is also recorded as having 716,000 shares of indirect beneficial ownership held by a former spouse, over which he has sole voting control but no pecuniary interest per the filing. The Form 4 was signed by an attorney-in-fact on 08/25/2025.
This Form 144 filed for Vital Farms, Inc. (VITL) reports a proposed sale of 4,796 common shares through Morgan Stanley Smith Barney LLC on 08/22/2025 with an aggregate market value of $244,347.09. The filing lists prior sales by the same person, JOANNE BAL, of 9,609 and 390 common shares on 08/15/2025 generating gross proceeds of $458,344.50 and $18,602.81, respectively. Acquisition details show the shares to be sold were received as restricted stock vesting under a registered plan on 03/10/2023 (42 shares), 03/13/2024 (3,294 shares), and 04/26/2024 (1,460 shares). The filer certifies no undisclosed material adverse information is known.
Vital Farms insider sale: Executive Chairperson and director Matthew Ohayer sold 800 shares on 08/19/2025 under a pre-established Rule 10b5-1 plan. The reported weighted-average sale price was $50.31, with individual trade prices ranging from $50.27 to $50.35. After the disposition the filing shows Mr. Ohayer directly beneficially owns 6,831,270 shares and is reported as the indirect beneficial owner of 716,000 shares held by his former spouse, over which he has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 08/21/2025 and discloses the plan adoption date of March 14, 2025.
Kathryn McKeon, CMO and GM, Butter at Vital Farms (VITL), reported scheduled insider transactions in August 2025. On 08/15/2025 she sold 12,005 shares under a Rule 10b5-1 plan at a weighted average price of $47.59, reducing her beneficial holdings to 37,513 shares. On 08/18/2025 she exercised and acquired 21,442 shares under an employee stock option with a $15.31 exercise price and simultaneously sold 21,442 shares at a weighted average price of $49.08. After these transactions she beneficially owns 58,955 shares (direct). The Form 4 discloses the 10b5-1 plan was adopted on May 16, 2025, and the option vests in three equal annual installments starting 03/13/2024.
Vital Farms officer Joanne Bal reported the sale of 9,999 shares of the company's common stock on 08/15/2025 at a weighted average price of $47.70 per share, with transaction prices ranging from $47.60 to $47.81. After the sale, the reporting person beneficially owned 48,128 shares, a total that includes 229 shares acquired under the company's Employee Stock Purchase Plan on 05/15/2025. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing identifies the reporting person as an officer with the title GC, SEC. AND HEAD OF IMPACT.
Form 144 for Vital Farms, Inc. (VITL) shows a proposed sale of 21,442 common shares valued at $1,023,855.50 to be executed on 08/18/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filing states these shares were acquired the same day by exercise of stock options from the issuer and paid in cash. The filer also reported recent 10b5-1 sales on 08/15/2025 of 12,005 shares generating $571,346.76. The filing includes an assurance that the signer does not possess undisclosed material adverse information.
Vital Farms insider sale by Director Denny Marie Post — On 08/14/2025 the reporting person sold 6,086 shares of Vital Farms, Inc. (VITL) common stock at a weighted average price of $47.75 per share. After the reported disposition the reporting person beneficially owned 16,312 shares. The filing notes the sale occurred in multiple transactions at prices ranging from $47.74 to $47.81 and that the signer, an attorney-in-fact, executed the Form 4 on behalf of the reporting person.
Vital Farms, Inc. CHIEF FINANCIAL OFFICER Wrede Thilo exercised employee stock options for 7,189 shares of Common Stock at $13.9100 per share on August 14, 2025, then sold 3,393 shares at weighted-average prices of $47.0600 and $47.7000 under a Rule 10b5-1 plan adopted May 15, 2025. Following these transactions, Thilo directly holds 58,783 shares of Common Stock and retains 14,378 option rights expiring March 17, 2033.
Notice of proposed sale of 9,999 common shares by a person associated with Vital Farms, Inc. (VITL). The filing names Morgan Stanley Smith Barney LLC as the broker and lists an aggregate market value of $476,947.30 for the shares, against 44,685,980 shares outstanding. The planned approximate sale date is 08/15/2025. The shares were acquired through restricted stock vesting on 03/10/2024 (9,609 shares) and 04/26/2024 (390 shares). The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information.